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Abstract
Objective To compare international diagnostic and management strategies for vestibular schwannoma (VS).
Methods A web-based questionnaire was sent to 130 otolaryngologists, mainly identified through the European Skull Base 
Society. It contained questions on general information including guideline usage as well as questions on diagnosis (focus-
sing on selection of patients for MRI) and management of VS, including case scenarios. Descriptive statistics were reported.
Results Thirty-six otolaryngologists working in 11 different countries completed the questionnaire (response rate: 28%). 
Guidelines for diagnosis and management of VS are used by 44% and 42% of respondents, respectively. In the diagnostic 
strategy for VS, different types and combinations of audiovestibular function tests are used when deciding whether a patient 
should undergo an MRI. Respondents apply 18 different definitions of asymmetrical hearing loss. Variation was also appar-
ent from reported considerations on management of VS. Most respondents (84%) prefer a wait-and-scan strategy in case of 
a small intrameatal VS (Koos 1). Variety in management strategies increases for patients with a medium to large sized VS 
(Koos 2, 3 and 4). The details of each management strategy (wait-and-scan, microsurgery, stereotactic radiosurgery and 
fractionated radiotherapy) also differ among respondents.
Conclusions A large variation in diagnostic and management strategies for VS was identified between respondents. More 
evidence and/or consensus seem warranted to reduce uncertainties for patients, and differences in outcome and costs that 
might result from the variety of strategies currently being applied.
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Introduction
Patients with a vestibular schwannoma (VS) usually pre-
sent with symptoms of (asymmetrical) sensorineural hear-
ing loss, tinnitus, vertigo and/or disequilibrium. Magnetic 
resonance imaging (MRI) is considered the gold standard 
to diagnose VS and is performed whenever there is a high 
suspicion of VS in patients with aforementioned symptoms 
[1]. It is, however, a challenge to determine which patients 
should undergo MRI, the reported yield of diagnostic MRIs 
being approximately 3% [2, 3]. There are several tests avail-
able that can help to determine whether a patient should be 
referred for MRI. Pure tone audiometry is usually the first 
step in the diagnostic process and is sometimes followed 
by other audiovestibular function tests, such as auditory 
brainstem response, speech perception tests and electronys-
tagmography [4, 5]. Although numerous studies examined 
the effectiveness of these audiovestibular function tests in 
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selecting patients for MRI [1, 5–7], there seems no consen-
sus regarding their role in everyday practice.
Apart from the variability in diagnostic strategies, there 
are multiple management strategies available for VS, con-
sisting of microsurgical resection, radiation therapy (frac-
tionated radiotherapy, stereotactic radiosurgery) or “wait-
and-scan” (W&S, observation with serial imaging aiming 
to detect tumour growth). Over the past years the W&S 
strategy has gained popularity in Europe and the US [8, 9]. 
Treatment is increasingly being reserved for patients with a 
large size and/or growing VS. Because the natural growth 
pattern of VS is variable and unpredictable [10, 11], it is 
a challenge to determine the time interval between MRIs 
in the W&S strategy as well as indications for, and type of 
treatment.
An international guideline concerning the diagnosis and 
management of VS is lacking. Specialists seem to counsel 
their patients based on personal preference and experience 
[12]. A lack of guidelines prescribing the appropriate use 
of various strategies may contribute to inconsistencies in 
care delivery among specialists. These, in turn, may lead to 
uncertainties for patients, unnecessary differences in out-
come between patients and unnecessary variation in costs 
associated with care. For these reasons, it is important to 
identify practice variations and possibilities to further 
improve healthcare.
In this study, we aimed to investigate variation in diag-
nostic and management strategies for VS across countries, 
and explore determinants of such variation.
Methods
Study design and population
To obtain information regarding the current diagnostic 
and management strategies for VS, an online questionnaire 
was sent to 102 otolaryngologists working in 15 different 
countries, that were registered in the European Skull Base 
Society database. We additionally invited 28 otolaryngolo-
gists whose contact details were acquired through hospital 
websites or by personal acquaintance (excluding the authors’ 
hospitals). The questionnaire was distributed using ‘Castor 
EDC’ [13] in January 2017. We sent two reminders in a time 
span of 2 weeks.
Questionnaire
The questionnaire is provided as Supplemental file 1. It con-
sisted of three main sections. The first section contained 
questions on general topics, e.g. patient volumes and guide-
line usage. The second section focused on audiovestibular 
function tests and investigated based on what parameters 
respondents refer a patient for MRI. In the third section 
different management strategies for VS were addressed, 
including the proportion of patients being assigned to each 
strategy, variables used when considering management strat-
egies, and their conduct. It included several case scenarios 
describing VSs of increasing size (see Fig. 1). Respondents 
chose the preferred management option for each case, which 
enabled us to further explore their considerations and assess 
impact on individual patients. The questionnaire was tested 
prior to its distribution, and adapted accordingly to the com-
ments received by two otolaryngologists, a professor in evi-
dence based surgery, a radiologist specialized in neuro- and 
head and neck radiology, and a junior researcher in the field 
of VS.
Data analysis
Diagnostic and management strategies were compared 
between respondents and countries, by providing descrip-
tive statistics. Percentages and medians or means were cal-
culated where applicable. Data were analyzed per item, so 
the denominator varied per question due to missing data. 
All analyses were performed using IBM SPSS Statistics for 
Windows, version 22 (IBM Corp., Armonk, N.Y., USA).
Results
Respondents
Of the 130 addressed, 36 otolaryngologists from 11 differ-
ent countries returned the questionnaire (response rate 28%) 
(Supplemental table 1), visited by a median of 85 (n = 32, 
range 3–300) patients with newly diagnosed VSs in 2016. 
All respondents (n = 36) indicated to work at a university 
hospital and the mean experience in working with VS 
patients was 16 years (SD 7.3).
The majority of respondents (56%) never uses a guideline, 
neither for diagnosis nor management. Despite the availabil-
ity of guidelines in the Netherlands (asymmetrical hearing 
loss and tinnitus) [14] and the United Kingdom (diagnosis 
and management) [9], heterogeneity was found in responses 
from these countries.
Thirty respondents (88%) participate in multidisciplinary 
meetings to discuss VS cases, while the remaining 4 (12%) 
do not have such meetings.
Diagnostic strategies
All respondents have MRI available, and most (79%) use 
contrast-enhanced MRI to diagnose VS. There was more 
variety regarding the use of audiovestibular function tests to 
select patients for MRI. Most respondents (n = 31, 94%) use 
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pure-tone audiometry in the diagnostic process, the remain-
ing two respondents solely relying on auditory brainstem 
response. We investigated the definition of asymmetrical 
hearing loss that respondents apply when referring patients 
for MRI. The minimum asymmetry of hearing loss being 
used ranged from 5 to 30 dB, 20 dB being mostly used 
Case 1
Scenario I:
A female patient of 50 years old in overall 
good health has symptoms of hearing loss 
and unilateral tinnitus in the right ear. 
Audiometry shows asymmetrical 
sensorineural hearing loss. You decide to 
screen this patient for VS by acquiring an 
MRI. It shows an intrameatal VS (Koos 
grade 1), 4 mm maximum diameter.
Scenario II:
W&S Scenario IIA: Same case, follow up after two years, hearing loss has 
worsened and MRI reveals significant growth of the VS.
No W&S Scenario IIB: Same case, different maximum diameter.
In both scenarios IIA and IIB MRI shows a VS extending in the CPA without 
contacting the brainstem (Koos grade 2).
Fig. 1  Case scenarios and MRI images used in the questionnaire
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Case 2
Scenario I:
A male patient of 65 years old in overall 
good condition has symptoms of hearing 
loss, a sense of pressure in the left ear and 
vertigo symptoms. Audiometry shows 
asymmetrical sensorineural hearing loss. 
MRI reveals a 13 mm maximum diameter 
VS, contacting the brainstem (Koos grade 
3). 
Scenario II:
W&S Scenario IIA: Same case, follow up after three years. The patient complaints 
of facial numbness and MRI reveals significant growth.
No W&S Scenario IIB: Same case, but additional complaints of facial numbness. 
MRI shows a VS with a different maximum diameter. 
In both scenarios IIA and IIB, MRI shows a lesion exerting pressure on the brainstem 
(Koos grade 4).
Fig. 1  (continued)
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(n = 11, 36%). Most respondents (n = 27, 87%) define asym-
metry as an absolute difference between ears at specific fre-
quencies, while 4 (13%) calculate a mean. However, how 
many and which frequencies are taken into account as well 
as their mutual relation (adjacent or non-adjacent) varies. 
Respondents provided 18 different definitions of asymmetri-
cal hearing loss, including 12 different combinations of fre-
quencies that are considered important. The most frequently 
reported definition (n = 6, 19%) uses an absolute asymmetry 
of 10 dB as threshold, followed by an absolute asymmetry 
of 20 dB (n = 4, 13%).
Twenty-four respondents (73%) usually perform speech 
audiometry to decide if a patient should undergo MRI. Most 
(n = 14, 58%) use speech reception thresholds.
Moreover, respondents explained to look for the roll-over 
phenomenon as well as discrepancy with pure-tone audiom-
etry measurements.
Twenty-one respondents (64%) order an MRI for patients 
with unilateral tinnitus as only symptom. Its duration var-
ied (0–11 months), but most respondents apply a minimum 
of 3 months (n = 6, 29%). Twenty-one respondents (64%) 
perform electronystagmography in case of vertigo and 16 
respondents (49%) use auditory brainstem response.
Additional audiovestibular function tests consisting 
of (video) head impulse tests and/or vestibular-evoked 
myogenic potentials are used by 4 and 3 respondents, 
respectively.
Management strategies
Most respondents (n = 15, 42%) deem tumour size the most 
important variable when deciding about management strat-
egies, followed by cerebellopontine angle size/intracranial 
space (n = 10, 28%). VS size is measured using dimensional 
and volumetric measurements by 27 (84%) and 5 (16%) 
respondents, respectively. Twenty respondents (63%) use a 
specific threshold in tumour size/volume when considering 
treatment, varying from 15 to 30 mm, a majority applying 
20 mm (n = 9, 45%). Five respondents (16%) base their deci-
sion to proceed to treatment on tumour size/volume only, 
while most (n = 15, 47%) also consider other variables (e.g. 
brainstem contact and/or compression, patient characteris-
tics and/or symptoms, and/or tumour growth).
In 2016, the proportion of VS patients assigned to each 
management strategy at time of diagnosis varied (Fig. 2). 
Both microsurgery and W&S were applied in all participat-
ing centres in varying proportions. Twenty-one respondents 
(70%) assigned a majority of patients to W&S, while only 5 
(17%) did so for microsurgery. Stereotactic radiosurgery was 
prescribed by more respondents (n = 22, 73%) than fraction-
ated radiotherapy (n = 11, 37%).
Wait‑and‑scan
Figure 3 provides a schematic overview of W&S strategies 
being used. Strategies vary in timing of the first MRI fol-
lowing diagnosis, interval periods and total duration of the 
observational period. Respondents quit the W&S strategy 
when a patient reaches a specific age (75 and 80 years), 
after a specified period (4–21 years), or continue lifelong. 
Most (n = 18, 56%) define significant tumour growth as 
an increase in diameter of ≥ 2 mm, while others apply an 
increase of ≥ 1 mm (22%) or a volume increase of ≥ 10% 
(9%). Ten respondents (31%) consider tumour growth a 
strict indication for treatment, whereas 69% also take other 
variables into account (e.g. tumour size, symptoms and/or 
patient age, health and/or preference).
Fig. 2  Fraction of VS patients 
assigned to management 
strategies at time of diagnosis, 
reported by 30 respondents. y 
axis: number of respondents, 
x axis: different management 
strategies at time of diagnosis
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Radiation therapy
Of the respondents prescribing stereotactic radiosurgery, 
most use Gamma Knife (n = 11, 52%). Fractionated radio-
therapy treatment plans were reported by 10 respondents and 
contain up to 30 fractions, with total dosages of 12–60 Gy.
Microsurgery
The microsurgical approach most frequently used by 
respondents is translabyrinthine (n = 20, 65%), followed 
by suboccipital (n = 6, 19%) and middle fossa (n = 5, 16%). 
Whenever the facial nerve is difficult to recognise intra-oper-
atively, most respondents (n = 29, 94%) opt for incomplete 
VS removal to reduce the risk of facial nerve injury.
Case scenarios
Table 1 displays the management strategies chosen for the 
different case scenarios (from Fig. 1). There is much agree-
ment about conservative management for small intrameatal 
VSs, W&S being the most popular choice (84%) for Case 
1—Scenario I. Even though all respondents indicated to 
allocate part of their patients to W&S, 5 (16%) preferred 
treatment over W&S for this scenario, motivated by the 
patient’s age (50 years) and chances of hearing preservation. 
For VSs extending in the CPA but not contacting the brain-
stem (Case 1—Scenario II) diversity in management choices 
becomes more apparent. For the VS that had grown during 
W&S (Case 1—Scenario IIA) some respondents would let 
the patient choose between W&S and treatment, and/or dif-
ferent treatment modalities. For the VS making brainstem 
contact (Case 2—Scenario I), preferred management options 
Fig. 3  Display of variation in 
applied wait-and-scan (W&S) 
strategies
Table 1  Management strategies 
chosen for two patients with 
different clinical characteristics
Scenarios were adapted to choices made in scenario I
W&S wait-and-scan, RS stereotactic radiosurgery, RT fractionated radiotherapy, MS microsurgery
a Respondents that had chosen a W&S strategy in scenario I
b Respondents that had chosen to proceed to treatment in scenario I
c Two respondents that completed Scenario I did not complete this question
Management 
strategy
Case 1 Case 2
Scenario I 
N = 32
[n (%)]
Scenario IIA 
n = 27a
[n (%)]
Scenario 
IIB n = 5b
[n (%)]
Scenario I 
N = 32
[n (%)]
Scenario IIA 
n = 16a
[n (%)]
Scenario IIB 
n = 16b,c
[n (%)]
W&S 27 (84) 4 (15) – 16 (50) 1 (6) –
RS – 11 (41) – 1 (3) 4 (25) –
RT 1 (3) – – 1 (3) 1 (6) –
MS 4 (13) 12 (44) 5 (100) 14 (44) 10 (63) 14 (88)
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consisted mostly of W&S or microsurgery. For the largest 
VS causing brainstem compression (Case 2—Scenario II) 
differences were reduced again, microsurgery being most 
popular. The case scenarios confirm that fractionated radio-
therapy is an uncommon treatment option for VS. Remark-
ably, some respondents working in the same centre chose 
different management options for the same case scenario. 
It seemed that otolaryngologists from high volume centers 
(> 100 new VS patients per year) preferred W&S over treat-
ment for Case 2—Scenario I. For the other case scenarios 
we could not identify a difference between low and high 
volume centers.
Between‑country comparisons
In the six countries with multiple responders, we identified 
a lot of heterogeneity making a comparison difficult. Some 
consistency was found in the UK, where most respondents 
use unenhanced MRI and all consider unilateral tinnitus (of 
various durations) as only symptom an indication for MRI. 
Respondents that mostly use the middle fossa approach 
work in Germany. Based on the case scenarios it seems that 
respondents working in Germany, the USA and France more 
often proceed to microsurgery compared to other countries.
Discussion
Our questionnaire regarding diagnostic and management 
strategies for VS identified and explored variations in clini-
cal practice. Less than half of respondents use a guideline for 
diagnosis and management. Respondents apply many differ-
ent strategies to select patients for MRI and apply different 
thresholds for treatment. The case scenarios emphasized the 
impact this has on choices for VS management in individual 
patients.
Our results are in agreement with a study that reported 
on variations in disease presentation and initial manage-
ment of small to medium sized VSs in the USA [12]. The 
study described place of residence as a stronger predictor 
for choice of management strategy than a patient’s age or 
VS size [12]. Next to referral patterns and availability of 
care, the authors contribute this to provider or institutional 
preference [12]. Naturally, in the current study, the propor-
tion of patients assigned to each management strategy can 
be partially attributed to differences in local availability of 
care and referral patterns. However, our study also points 
out the various thresholds that otolaryngologists apply for 
diagnosis and management of VS, which will not depend 
on latter factors.
To our knowledge this is the first study to provide 
an overview of international differences in diagnosis 
and management of VS. The reliability of our data is 
dependent on accurate reporting of each otolaryngologist, 
which seems fair. However, selection of respondents can-
not be precluded. Our results may, therefore, not comprise 
all strategies that are currently being used for diagnosis 
and management of VS. However, most included respond-
ents work in high-volume centres and are responsible for 
consulting a substantial amount of VS patients. Further-
more, the variation might only further increase rather than 
becoming less after including more otolaryngologists. 
Preferably we would have achieved a higher response 
rate. Some non-responders motivated why they did not 
participate (i.e. retirement, no otolaryngologist, working 
in a private practice). Of the invited people, there was a 
larger proportion of professors that did not respond. Fur-
thermore, we could not identify any differences between 
responders and non-responders. We deliberately limited 
our study population to otolaryngologists as we wanted 
to use one general questionnaire for both diagnosis and 
management of VS. Neurosurgeons compose an important 
link in the management of VS patients. However, otolar-
yngologists will be aware of the management of patients 
in their clinic/region, although they might not be treating 
them in person.
The lack of uniformity in diagnosis and management of 
VS is emphasized by the current study. The reported diag-
nostic work-up showed great variation, remarkably even 
by respondents from the same centre. The case scenarios 
revealed that this variation has an even greater impact on 
management strategies for individual patients than we had 
expected. Every otolaryngologist should realise that a patient 
might be managed differently elsewhere, even by a colleague 
within their own centre. We believe this information should 
not be neglected during patient counselling.
The current study cannot confirm whether different strate-
gies also lead to differences in patient outcomes and costs. 
However, considering the extent of differences this does 
seem inevitable. The same patient might or might not be 
selected to undergo an MRI when visiting a different otolar-
yngologist. It is also, for example, known that facial nerve 
and hearing outcomes differ following radiation therapy and 
microsurgery [15]. It should be noted that experience with 
a certain treatment modality affects the results achieved. 
What sources of information underlie current strategies is 
largely unclear. Factors such as the training or reimburse-
ments received by participants, participants’ age, access to 
diagnostic means and treatment and involvement in research 
projects might influence choices made. It seems that more 
evidence and/or consensus could reduce uncertainties for 
patients as well as potential differences in outcome and asso-
ciated costs. Based on the currently available evidence, it is 
difficult to state what diagnostic strategy should be followed 
[4]. Moreover, there is a lack of evidence (functional out-
comes and quality of life) on different treatment modalities 
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stratified according to VS size. Combined with the current 
variety in applied strategies, this constitutes a challenge 
to implement an (inter)national guideline. Therefore, we 
encourage the exchange of evidence and considerations 
between otolaryngologists to try to reach consensus on a(n) 
(inter)national level.
Conclusion
There is a high variability regarding diagnostic and man-
agement strategies for VS between otolaryngologists across 
countries. Otolaryngologists working in this field should 
realise these differences exist to optimize patient counsel-
ling. Further exploration of this variability may provide 
opportunities to synthesize the available evidence and to 
discuss possibilities to reach consensus.
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